Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting® Pharmaceutical Investing
Harmony Biosciences to Participate in 25th Annual Needham Virtual Healthcare Conference Life Science Investing
Enveric Biosciences Secures New U.S. Patent for Its EVM301 Series of Drug Candidates Life Science Investing
Cocrystal Pharma Reports 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs Life Science Investing
Galectin Therapeutics Reports 2025 Financial Results and Provides Business Update Life Science Investing
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting Life Science Investing
Palvella Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update Life Science Investing
MiNK Therapeutics Reports Q4 and Full Year 2025 Results; Phase 2 Programs Advance with Impactful Non-Dilutive Momentum Life Science Investing
Biogen to Acquire Apellis, Enhancing the Company's Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology Life Science Investing
Bristol Myers Squibb Evolves and Expands Standing in the Gaap to Advance More Equitable Care in Multiple Myeloma as Program Marks Ten Years Life Science Investing
